ASIC1 (Acid-sensing ion channel 1) variants and mutations
ASIC1 (also known as Acid-sensing ion channel 1) is a human protein-coding gene encoding an acid-sensing ion channel 1 protein. The protein forms a pH-gated trimeric sodium channel that acts as an excitatory receptor in the nervous system. When extracellular conditions become more acidic, the channel produces a rapid inward current that can influence synaptic plasticity, learning, and memory. This analysis covers 864 ASIC1 variants and mutations. Of these, 99% have computational variant effect predictions. Disease context includes Seizure, neoplasm, and breast cancer. Example ASIC1 variants include M1V, M1R, and M1I.
Variant analysis overview
- Gene: ASIC1
- Protein: Acid-sensing ion channel 1
- UniProt accession: P78348
- Organism: Homo sapiens
- Variants analyzed: 864
- Variant scope: all variants
- Completed: 2026-06-08
Variant and mutation evidence
- Variant composition: 520 unspecified-consequence records; 11 stop-gained variants; 187 missense variants; 10 in-frame deletions; 112 synonymous variants; 5 in-frame insertions; 18 frameshift variants; 1 substitution
- Prediction scores: 856 variants have prediction scores (99% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Seizure, neoplasm, breast cancer, schizophrenia, hypertriglyceridemia 2, glioblastoma multiforme, liver cancer, atherosclerosis, gastroesophageal reflux disease, Combined hyperlipidemia, fish eye disease, Fish-eye disease.
Protein structure and variant hotspots
- Protein features: 2 transmembrane segments; 4 post-translational modification sites.
- Structural context: 87 variants have structural context.
- PTM context: 5 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, PharmGKB, MaveDB, LitVar.
Notable ASIC1 variants
Examples include M1V, M1R, M1I, E2K, E2*, E2D, L3P, K4N. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1V (p.Met1Val), rs1335987038, gnomAD 12-50073609-A-G, REVEL 0.04, ESM-1b 0.00
- M1R (p.Met1Arg), gnomAD 12-50073610-T-G, REVEL 0.11, ESM-1b 0.00
- M1I (p.Met1Ile), rs1416728533, gnomAD 12-50073611-G-A, REVEL 0.09, ESM-1b 1.00
- E2K (p.Glu2Lys), ExAC rs748123096, TOPMed rs748123096, gnomAD rs748123096, REVEL 0.20, ESM-1b 0.00
- E2* (p.Glu2Ter), gnomAD 12-50058770-G-T, CADD 38.00
- E2D (p.Glu2Asp), gnomAD 12-50058772-A-C, REVEL 0.14, ESM-1b 0.00
- L3P (p.Leu3Pro), gnomAD 12-50058774-T-C, REVEL 0.23, ESM-1b 0.00
- K4N (p.Lys4Asn), cosmic curated COSV57319, REVEL 0.18, ESM-1b 0.50
- p.Lys4 Ala5del, gnomAD 12-50058775-GAAGG, CADD 20.30
- K4M (p.Lys4Met), gnomAD 12-50058777-A-T, REVEL 0.34, ESM-1b 0.64
- A5V (p.Ala5Val), NCI-TCGA TCGA novel, REVEL 0.08, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- A5T (p.Ala5Thr), gnomAD 12-50058779-G-A, REVEL 0.13, ESM-1b 0.00
- A5A (p.Ala5Ala), rs773285015, gnomAD 12-50058781-C-T, CADD 9.96
- E6A (p.Glu6Ala), TOPMed rs1950471188, gnomAD rs1950471188, REVEL 0.08, ESM-1b 0.00
- E6G (p.Glu6Gly), TOPMed rs1950471188, gnomAD rs1950471188, REVEL 0.07, ESM-1b 0.00
- E6K (p.Glu6Lys), TOPMed rs1191015788, gnomAD rs1191015788, REVEL 0.11, ESM-1b 0.00, Uncertain significance, not specified
- E6Q (p.Glu6Gln), rs1191015788, ClinGen CA384775512, ClinVar RCV004420761, TOPMed rs1191015788, REVEL 0.11, ESM-1b 0.00, Uncertain significance, not specified
- E7K (p.Glu7Lys), gnomAD 12-50058785-G-A, REVEL 0.15, ESM-1b 0.00
- E7G (p.Glu7Gly), gnomAD 12-50058786-A-G, REVEL 0.10, ESM-1b 0.00
- E7V (p.Glu7Val), gnomAD 12-50058786-A-T, REVEL 0.14, ESM-1b 1.00
- E8D (p.Glu8Asp), ExAC rs772074112, gnomAD rs772074112, REVEL 0.03, ESM-1b 0.00
- E8K (p.Glu8Lys), NCI-TCGA Cosmic COSV5731, cosmic curated COSV57317, REVEL 0.15, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- E8G (p.Glu8Gly), gnomAD 12-50058789-A-G, REVEL 0.14, ESM-1b 0.00
- E8E (p.Glu8Glu), rs772074112, gnomAD 12-50058790-G-A, CADD 9.84
- p.Glu9dup, rs1565723020, gnomAD 12-50058781-C-CGA, CADD 21.40
- E9del (p.Glu9del), rs1565723020, gnomAD 12-50058781-CGAG-, CADD 21.00
- E9A (p.Glu9Ala), gnomAD 12-50058792-A-C, REVEL 0.13, ESM-1b 0.00
- E9E (p.Glu9Glu), rs745899518, gnomAD 12-50058793-G-A, CADD 11.50
- E9G (p.Glu9Gly), gnomAD 12-50073628-A-G, REVEL 0.11, ESM-1b 0.00
- E9K (p.Glu9Lys), rs1360861584, gnomAD 12-50073630-G-A, REVEL 0.15, ESM-1b 0.00
- E9* (p.Glu9Ter), gnomAD 12-50073630-G-T, CADD 17.50
- V10G (p.Val10Gly), cosmic curated COSV57318, Ensembl rs1592263163, ESM-1b 0.00, AlphaMissense 0.06
- V10M (p.Val10Met), TOPMed rs1367576407, REVEL 0.06, ESM-1b 0.00
- p.Val10dup, gnomAD 12-50058792-A-AGG, CADD 19.60
- V10V (p.Val10Val), rs770176996, gnomAD 12-50058796-G-A, CADD 11.90
- G11D (p.Gly11Asp), TOPMed rs1450857095, REVEL 0.08, ESM-1b 0.00, Uncertain significance, not specified
- G11S (p.Gly11Ser), gnomAD 12-50058797-G-A, REVEL 0.08, ESM-1b 0.00
- G11G (p.Gly11Gly), gnomAD 12-50058799-T-A, CADD 12.50
- G12D (p.Gly12Asp), cosmic curated COSV57316, REVEL 0.05, ESM-1b 0.00
- G12V (p.Gly12Val), 1000Genomes rs562333224, ExAC rs562333224, TOPMed rs562333224, gnomAD rs562333224, REVEL 0.06, ESM-1b 0.00
- G12G (p.Gly12Gly), rs145170340, gnomAD 12-50058802-C-T, CADD 8.28
- G12R (p.Gly12Arg), gnomAD 12-50073624-G-A, REVEL 0.08, ESM-1b 0.00
- G12W (p.Gly12Trp), gnomAD 12-50073639-G-T, REVEL 0.06, ESM-1b 1.00
- G12E (p.Gly12Glu), gnomAD 12-50073640-G-A, REVEL 0.04, ESM-1b 0.00
- V13A (p.Val13Ala), Ensembl rs1592263193, REVEL 0.07, ESM-1b 0.00
- V13F (p.Val13Phe), ESP rs368761955, ExAC rs368761955, TOPMed rs368761955, gnomAD rs368761955, REVEL 0.06, ESM-1b 0.00, Uncertain significance, not specified
- V13I (p.Val13Ile), rs368761955, cosmic curated COSV57317, ESP rs368761955, ExAC rs368761955, REVEL 0.05, ESM-1b 0.15, Uncertain significance, not specified
- V13L (p.Val13Leu), ESP rs368761955, ExAC rs368761955, TOPMed rs368761955, gnomAD rs368761955, REVEL 0.09, ESM-1b 0.00
- V13V (p.Val13Val), rs376322572, gnomAD 12-50058805-C-A, CADD 10.60
- Q14Q (p.Gln14Gln), rs767973296, gnomAD 12-50058808-G-A, CADD 10.80
- P15L (p.Pro15Leu), ExAC rs749977160, TOPMed rs749977160, gnomAD rs749977160, REVEL 0.46, ESM-1b 1.00, Uncertain significance
- P15R (p.Pro15Arg), rs749977160, ClinGen CA6560486, ClinVar RCV004172779, ExAC rs749977160, REVEL 0.34, ESM-1b 1.00, Uncertain significance, not specified
- P15S (p.Pro15Ser), gnomAD 12-50058809-C-T, REVEL 0.26, ESM-1b 1.00
- P15P (p.Pro15Pro), rs760156855, gnomAD 12-50058811-G-C, CADD 9.74
- P15T (p.Pro15Thr), gnomAD 12-50073588-C-A, REVEL 0.16, ESM-1b 1.00
- P15A (p.Pro15Ala), gnomAD 12-50073588-C-G, REVEL 0.18, ESM-1b 1.00
- P15H (p.Pro15His), rs973616694, gnomAD 12-50073589-C-A, REVEL 0.25, ESM-1b 1.00
- p.Val16dup, gnomAD 12-50058810-C-CGG, CADD 20.50
- V16* (p.Val16Ter), rs762883637, gnomAD 12-50058810-CG-C, CADD 23.10
- V16L (p.Val16Leu), gnomAD 12-50058812-G-T, REVEL 0.07, ESM-1b 0.00
- S17I (p.Ser17Ile), gnomAD 12-50058816-G-T, REVEL 0.21, ESM-1b 1.00
- S17N (p.Ser17Asn), gnomAD 12-50058816-G-A, REVEL 0.08, ESM-1b 0.00
- S17R (p.Ser17Arg), gnomAD 12-50058817-C-A, REVEL 0.21, ESM-1b 0.94
- S17S (p.Ser17Ser), rs1364272171, gnomAD 12-50058817-C-T, CADD 14.80
- S17Y (p.Ser17Tyr), gnomAD 12-50073607-C-A, REVEL 0.13, ESM-1b 1.00
- S17F (p.Ser17Phe), gnomAD 12-50073607-C-T, REVEL 0.10, ESM-1b 1.00
- S17T (p.Ser17Thr), gnomAD 12-50073612-T-A, REVEL 0.08, ESM-1b 0.00
- S17P (p.Ser17Pro), gnomAD 12-50073612-T-C, REVEL 0.10, ESM-1b 0.00
- S13del (p.Ser13del), gnomAD 12-50073616-TCTC-, CADD 15.50
- I18L (p.Ile18Leu), gnomAD rs1428383855, REVEL 0.12, ESM-1b 1.00
- I18F (p.Ile18Phe), rs1409507590, gnomAD 12-50073591-A-T, REVEL 0.06, ESM-1b 1.00
- I18T (p.Ile18Thr), gnomAD 12-50073592-T-C, REVEL 0.15, ESM-1b 1.00
- I18I (p.Ile18Ile), gnomAD 12-50073593-C-A, CADD 14.20
- I18V (p.Ile18Val), rs1168455597, gnomAD 12-50073597-A-G, REVEL 0.11, ESM-1b 0.03
- I18M (p.Ile18Met), gnomAD 12-50073599-C-G, REVEL 0.10, ESM-1b 1.00
- Q19P (p.Gln19Pro), rs997848433, ClinGen CA236725479, ClinVar RCV004296372, gnomAD rs997848433, REVEL 0.43, ESM-1b 0.00, Uncertain significance, not specified
- p.Gln34dup, gnomAD 12-50073674-T-TCA, CADD 4.92
- Q34del (p.Gln34del), rs1243010501, gnomAD 12-50073674-TCAG-, CADD 7.88
- Q19K (p.Gln19Lys), rs1475227482, gnomAD 12-50073675-C-A, REVEL 0.12, ESM-1b 1.00
- Q19* (p.Gln19Ter), rs1475227482, gnomAD 12-50073675-C-T, CADD 6.81
- Q19R (p.Gln19Arg), gnomAD 12-50073676-A-G, REVEL 0.02, ESM-1b 0.56
- Q19Q (p.Gln19Gln), gnomAD 12-50073677-G-A, CADD 8.98
- Q19H (p.Gln19His), rs540023446, gnomAD 12-50073677-G-T, REVEL 0.03, ESM-1b 0.00
- A20V (p.Ala20Val), gnomAD 12-50058825-C-T, REVEL 0.11, ESM-1b 0.00
- A20A (p.Ala20Ala), rs1950472107, gnomAD 12-50058826-C-T, CADD 13.50
- A20S (p.Ala20Ser), rs1950621279, gnomAD 12-50073633-G-T, REVEL 0.04, ESM-1b 0.00
- A20G (p.Ala20Gly), rs904908428, gnomAD 12-50073634-C-G, REVEL 0.07, ESM-1b 0.83
- F21F (p.Phe21Phe), rs766009896, gnomAD 12-50058829-C-T, CADD 11.40
- F6del (p.Phe6del), gnomAD 12-50073597-ATCT-, CADD 16.60
- F21L (p.Phe21Leu), gnomAD 12-50073615-T-C, REVEL 0.21, ESM-1b 1.00
- F21C (p.Phe21Cys), rs150732326, gnomAD 12-50073616-T-G, REVEL 0.13, ESM-1b 1.00
- F21S (p.Phe21Ser), gnomAD 12-50073616-T-C, REVEL 0.16, ESM-1b 1.00
- A22T (p.Ala22Thr), NCI-TCGA Cosmic COSV5732, cosmic curated COSV57320, REVEL 0.53, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- A22G (p.Ala22Gly), gnomAD 12-50058831-C-G, REVEL 0.47, ESM-1b 1.00
- A22D (p.Ala22Asp), gnomAD 12-50058831-C-A, REVEL 0.70, ESM-1b 1.00
- S23I (p.Ser23Ile), cosmic curated COSV57320, REVEL 0.35, ESM-1b 1.00
- S23S (p.Ser23Ser), gnomAD 12-50058835-C-T, CADD 12.70
- S24G (p.Ser24Gly), Ensembl rs61731225, REVEL 0.15, ESM-1b 0.00
- S24N (p.Ser24Asn), gnomAD rs1218229701, REVEL 0.10, ESM-1b 0.00
- S25C (p.Ser25Cys), TOPMed rs1434311522, gnomAD rs1434311522, REVEL 0.34, ESM-1b 0.46
- S25S (p.Ser25Ser), rs1331660653, gnomAD 12-50058841-C-T, CADD 12.50
- T26T (p.Thr26Thr), rs74090033, gnomAD 12-50058844-A-G, CADD 3.91
- L27W (p.Leu27Trp), rs1565729570, gnomAD 12-50073638-AG-A, CADD 13.40
- L27M (p.Leu27Met), rs1302776584, gnomAD 12-50073645-T-A, REVEL 0.06, ESM-1b 1.00
- L27L (p.Leu27Leu), rs1302776584, gnomAD 12-50073645-T-C, CADD 8.52
- L27S (p.Leu27Ser), rs1950621528, gnomAD 12-50073646-T-C, REVEL 0.03, ESM-1b 1.00
- L27F (p.Leu27Phe), gnomAD 12-50073647-G-C, REVEL 0.05, ESM-1b 1.00
- H28H (p.His28His), rs1384932994, gnomAD 12-50058850-C-T, CADD 10.30
- p.His29 His30del, gnomAD 12-50073664-CCCAC, CADD 12.30
- H28N (p.His28Asn), gnomAD 12-50073666-C-A, REVEL 0.04, ESM-1b 1.00
- H28Y (p.His28Tyr), rs892182976, gnomAD 12-50073666-C-T, REVEL 0.03, ESM-1b 1.00
- H28Q (p.His28Gln), rs935354947, gnomAD 12-50073668-C-A, REVEL 0.04, ESM-1b 1.00
- H28D (p.His28Asp), rs1009423847, gnomAD 12-50073669-C-G, REVEL 0.09, ESM-1b 1.00
- G29S (p.Gly29Ser), rs754524092, NCI-TCGA Cosmic COSV5731, cosmic curated COSV57317, ExAC rs754524092, REVEL 0.93, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- G29G (p.Gly29Gly), rs895426233, gnomAD 12-50058853-C-A, CADD 11.70
- G29C (p.Gly29Cys), rs1053497326, gnomAD 12-50073660-G-T, REVEL 0.02, ESM-1b 1.00
- G29R (p.Gly29Arg), rs1053497326, gnomAD 12-50073660-G-C, REVEL 0.03, ESM-1b 1.00
- G29V (p.Gly29Val), rs1950621674, gnomAD 12-50073661-G-T, REVEL 0.03, ESM-1b 1.00
- G29D (p.Gly29Asp), gnomAD 12-50073661-G-A, REVEL 0.05, ESM-1b 1.00
- L30L (p.Leu30Leu), rs778784628, gnomAD 12-50058856-G-A, CADD 11.30
- A31T (p.Ala31Thr), Ensembl rs953414982, REVEL 0.15, ESM-1b 0.00
- A31A (p.Ala31Ala), gnomAD 12-50058859-C-T, CADD 11.10
- H32Y (p.His32Tyr), cosmic curated COSV57319, REVEL 0.50, ESM-1b 1.00
- H32R (p.His32Arg), gnomAD 12-50058861-A-G, REVEL 0.59, ESM-1b 1.00
- H32H (p.His32His), rs752489002, gnomAD 12-50058862-C-T, CADD 11.30
- I33V (p.Ile33Val), ESP rs371256324, ExAC rs371256324, gnomAD rs371256324, REVEL 0.15, ESM-1b 0.38
- I33N (p.Ile33Asn), gnomAD 12-50073691-T-A, REVEL 0.02, ESM-1b 1.00
- I33I (p.Ile33Ile), gnomAD 12-50073692-C-A, CADD 4.55
- F34del (p.Phe34del), gnomAD 12-50058863-ATCT-, CADD 20.40
- F34F (p.Phe34Phe), rs374837952, gnomAD 12-50058868-C-T, CADD 13.40
- S35C (p.Ser35Cys), gnomAD 12-50058867-TCTCC, CADD 32.00
- S35del (p.Ser35del), gnomAD 12-50058867-TCTC-, CADD 19.70
- S35T (p.Ser35Thr), gnomAD 12-50073693-T-A, REVEL 0.09, ESM-1b 0.00
- S35P (p.Ser35Pro), gnomAD 12-50073693-T-C, REVEL 0.07, ESM-1b 1.00
- S35L (p.Ser35Leu), gnomAD 12-50073694-C-T, REVEL 0.06, ESM-1b 0.27
- S35* (p.Ser35Ter), gnomAD 12-50073694-C-A, CADD 6.78
- S35S (p.Ser35Ser), gnomAD 12-50073695-A-G, CADD 0.10
- Y36C (p.Tyr36Cys), gnomAD rs1369370966, REVEL 0.42, ESM-1b 1.00
- Y36D (p.Tyr36Asp), gnomAD 12-50058872-T-G, REVEL 0.35, ESM-1b 1.00
- Y36Y (p.Tyr36Tyr), rs769980036, gnomAD 12-50058874-C-T, CADD 6.30
- E37K (p.Glu37Lys), rs1025157825, NCI-TCGA Cosmic COSV5731, cosmic curated COSV57319, TOPMed rs1025157825, REVEL 0.24, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- E37Q (p.Glu37Gln), TOPMed rs1025157825, gnomAD rs1025157825, REVEL 0.22, ESM-1b 1.00
- E37A (p.Glu37Ala), gnomAD 12-50058874-CGA-C, CADD 28.60
- E37V (p.Glu37Val), gnomAD 12-50073697-A-T, REVEL 0.09, ESM-1b 1.00
- E37D (p.Glu37Asp), gnomAD 12-50073698-A-T, REVEL 0.06, ESM-1b 0.26
- E37* (p.Glu37Ter), gnomAD 12-50073702-G-T, CADD 14.50
- E37G (p.Glu37Gly), gnomAD 12-50073703-A-G, REVEL 0.06, ESM-1b 0.00
- E37E (p.Glu37Glu), rs1017512622, gnomAD 12-50073707-G-A, CADD 13.90
- E45del (p.Glu45del), rs1294914654, gnomAD 12-50073710-GGAA-, CADD 14.60
- R38Q (p.Arg38Gln), ExAC rs780207910, TOPMed rs780207910, gnomAD rs780207910, REVEL 0.23, ESM-1b 0.64, Uncertain significance, not specified
- R38W (p.Arg38Trp), NCI-TCGA TCGA novel, REVEL 0.46, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- R38P (p.Arg38Pro), gnomAD 12-50058879-G-C, REVEL 0.33, ESM-1b 1.00
- R38R (p.Arg38Arg), gnomAD 12-50058880-G-A, CADD 11.50
- S40* (p.Ser40Ter), rs750109464, gnomAD 12-50073700-C-A, CADD 14.40
- S40L (p.Ser40Leu), rs750109464, gnomAD 12-50073700-C-T, REVEL 0.07, ESM-1b 1.00
- S40W (p.Ser40Trp), gnomAD 12-50073700-C-G, REVEL 0.08, ESM-1b 1.00
- S40S (p.Ser40Ser), rs755486387, gnomAD 12-50073701-G-A, CADD 0.07
- L41L (p.Leu41Leu), gnomAD 12-50058887-C-T, CADD 11.60
- K42R (p.Lys42Arg), gnomAD 12-50058891-A-G, REVEL 0.10, ESM-1b 0.91
- K42N (p.Lys42Asn), gnomAD 12-50058892-G-T, REVEL 0.20, ESM-1b 1.00
- K42K (p.Lys42Lys), rs1222342049, gnomAD 12-50073722-G-A, CADD 12.50
- K42G (p.Lys42Gly), rs1393449931, gnomAD 12-50073732-GCAGT, CADD 8.49
- K42T (p.Lys42Thr), rs1950622965, gnomAD 12-50073738-AGGAA, CADD 14.20
- K42* (p.Lys42Ter), gnomAD 12-50073741-A-T, CADD 6.50
- K42E (p.Lys42Glu), gnomAD 12-50073741-A-G, REVEL 0.06, ESM-1b 1.00
- K42M (p.Lys42Met), gnomAD 12-50073742-A-T, REVEL 0.05, ESM-1b 1.00
- R43Q (p.Arg43Gln), NCI-TCGA Cosmic COSV5731, cosmic curated COSV57318, TOPMed rs1950472946, REVEL 0.54, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- R43W (p.Arg43Trp), ExAC rs749528528, TOPMed rs749528528, gnomAD rs749528528, REVEL 0.81, ESM-1b 1.00
- R43G (p.Arg43Gly), gnomAD 12-50058893-C-G, REVEL 0.85, ESM-1b 1.00
- R43P (p.Arg43Pro), gnomAD 12-50058894-G-C, REVEL 0.83, ESM-1b 1.00
- R43K (p.Arg43Lys), gnomAD 12-50073739-G-A, REVEL 0.02, ESM-1b 0.00
- R43M (p.Arg43Met), gnomAD 12-50073739-G-T, REVEL 0.01, ESM-1b 1.00
- R43S (p.Arg43Ser), gnomAD 12-50073740-G-T, REVEL 0.07, ESM-1b 1.00
- R43R (p.Arg43Arg), gnomAD 12-50073740-G-A, CADD 7.63
- A44V (p.Ala44Val), NCI-TCGA TCGA novel, REVEL 0.10, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- A44E (p.Ala44Glu), gnomAD 12-50058897-C-A, REVEL 0.37, ESM-1b 1.00
- L45P (p.Leu45Pro), ExAC rs768700646, gnomAD rs768700646, REVEL 0.83, ESM-1b 1.00
- L45A (p.Leu45Ala), gnomAD 12-50058876-A-AGC, CADD 26.70
- L45L (p.Leu45Leu), gnomAD 12-50058899-C-T, CADD 11.30
- W46* (p.Trp46Ter), cosmic curated COSV10505, CADD 38.00
Public ASIC1 analysis runs
- ASIC1 analysis run — ASIC1 (864 variants) — completed 2026-06-08